Skip Navigation LinksHome > August 2011 - Volume 11 - Issue 4 > Biologic modulators in allergic and autoinflammatory disease...
Current Opinion in Allergy & Clinical Immunology:
doi: 10.1097/ACI.0b013e328348a882
Pharmacotherapy and evidence based medicine: Edited by David A. Khan and Enrico Compalati

Biologic modulators in allergic and autoinflammatory diseases

Broderick, Lori; Tourangeau, Louanne M.; Kavanaugh, Arthur; Wasserman, Stephen I.

Collapse Box


Purpose of review: The advent of molecular techniques has resulted in the ability to tailor medications to specific protein targets. This review will emphasize several biological therapies, specifically directed toward cytokine receptors and inhibitors, and their role in the treatment of atopic and autoinflammatory diseases.

Recent findings: Translational research and the identification of the molecular pathophysiology of diseases have led to more targeted treatment approaches. The biologic modulators encompassing monoclonal antibodies as cytokine inhibitors, receptor blocking antibodies, and new fusion receptors are now being applied to diseases beyond their original application.

Summary: The expanded use of biological therapies has experienced success in the treatment of numerous disorders, especially in subsets of patients with disease that has been refractory to conventional therapies.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.